Lentiviral vector-based insertional mutagenesis identifies new clinically relevant cancer genes involved in the pathogenesis of hepatocellular carcinoma
2011-01-01 Ranzani, M; Cesana, D; Bartholomae, C; Sanvito, F; Pala, M; Benedicenti, F; Gallina, P; Sergi, L; Merella, S; Bulfone, A; Doglioni, C; von Kalle, C; Kim, Yj; Schmidt, M; Tonon, G; Naldini, L; Montini, E
Association between DNA repair polymorphisms and survival in cancer cancer patients treated with combination chemotherapy
2010-01-01 Pacetti, P; Giovanetti, E; Reni, M; Mambrini, A; Ghidini, M; Gleon, L; Funel, N; Cereda, S; Peters, G; Cantore, M.
Loss of the Histone Demethylase UTX Contributes to Multiple Myeloma and Sensitizes Cells to EZH2 Inhibitors
2014-01-01 Ezponda, T; Popovic, R; Zheng, Yp; Nabet, B; Will, C; Small, Ec; Occhionorelli, M; Tonon, G; Keats, Jj; Kelleher, Nl; Licht, Jd
Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine in pancreatic cancer: a randomized phase II trial
2009-01-01 Reni, M; Cereda, S; Aprile, G; Tronconi, Mc; Milandri, C; Passoni, P; Rognone, A; Balzano, G; Di Carlo, V; Villa, E
Up-regulation of c-Jun contributes to induction of apoptosis by Adaphostin in human multiple myeloma cells
2005-01-01 Podar, K; Tonon, G; Raab, Ms; Sattler, M; Abtahi, D; Tai, Yt; Legouill, S; Ishitsuka, K; Yasui, H; Depinho, Ra; Hideshima, T; Chauhan, D; Anderson, Kc
TUMOR DOWNSTAGING AND SPHINCTER PRESERVATION WITH PREOPERATIVE CHEMORADIOTHERAPY FOR RECTAL CANCER
2004-01-01 Ronzoni, M; Vitali, G; Reni, M; Di Palo, S; Staudacher, C; Villa, E
HIGH-THROUGHPUT SEQUENCING FOR THE IDENTIFICATION OF DIS3 MUTATIONS IN MULTIPLE MYELOMA
2015-01-01 Barbieri, M; Lionetti, M; Todoerti, K; Agnelli, L; Fabris, S; Cifola, I; Pinatel, E; Tonon, G; Segalla, S; Baldini, L; Neri, A
Adjuvant chemotherapy in ductal adenocarcinoma of pancreas: a comparison among three regimens
2002-01-01 Reni, M; Panucci, Mg; Balzano, G; Ferreri, Aj; Passoni, P; Zerbi, A; Cordio, S; Ceresoli, Gl; Dell'Oro, S; Staudacher, C; Di Carlo, V; Villa, E.
The AP-1 Transcription Factor JunB Promotes Multiple Myeloma (MM) Cell Proliferation, Survival and Drug Resistance in the Bone Marrow Microenvironment
2014-01-01 Fan, Fj; Vallet, S; Sattler, M; Tonon, G; Bashari, Mh; Bakiri, L; Goldschmidt, H; Wagner, Ef; Jaeger, D; Podar, K
Hypofractioniated (HF) RT of locally advanced pancreatic cancer: A planning design
2006-01-01 Cattaneo, G; Passoni, P; Esposito, D; Bettinardi, B; Reni, M; Broggi, S; Tamborra, P; Di Muzio, N; Fazio, F; Calandrino, R
Maintenance sunitinib (MS) or observation (O) in metastatic pancreatic adenocarcinoma (MPA): Clinical and translational results of a phase II randomized trial
2012-01-01 Reni, M; Cereda, S; Milella, M; Novarino, A; Passardi, A; Mambrini, A; Di Lucca, G; Ferrari, L; Belli, C; Danova, M; Bergamo, F; Franceschi, E; Rovati, B; Fugazza, C; Ceraulo, D; Villa, E
Targeting PKC informs in MM by enzastaurin (LY317615.HCL)
2007-01-01 Raab, Ms; Podar, K; Zhang, J; Tonon, G; Mcmillin, D; Breitkreutz, I; Tai, Yt; Lin, B; Munshi, N; Hideshima, T; Chauhan, D; Anderson, Kc
A RANDOMIZED PHASE II TRIAL OF TWO DIFFERENT FOUR DRUG COMBINATIONS IN ADVANCED PANCREATIC ADENOCARCINOMA: CISPLATIN, CAPECITABINE, GEMCITABINE PLUS EITHER EPIRUBICIN OR DOCETAXEL
2009-01-01 Cereda, S; Reni, M; Rognone, A; Ghidini, M; Rezzonico, S; Passoni, P; Mazza, E; Belli, C; Zerbi, A; Villa, E
The Role of the ABL1/YAP1/P73 Axis in Prevention of DNA Damage-Mediated Apoptosis in Multiple Myeloma
2012-01-01 Cottini, F; Hideshima, T; Sattler, M; Caligaris-Cappio, F; Anderson, Kc; Tonon, G
Recurrent glioblastoma multiforme: a multicenter phase II study with fractionated temozolomide (bid) plus cisplatin
2002-01-01 Basso, U; Vastola, F; Reni, M; Et, Al.
CS1 Promotes Multiple Myeloma Cell Adhesion, Clonogenic Growth, and Tumorigenicity Via C-Maf-Mediated Interactions with Bone Marrow Stromal Cells (BMSC)
2008-01-01 Tai, Yt; Soydan, E; Fulciniti, M; Song, Wh; Li, Xf; Burger, P; Hong, Fx; Tonon, G; Kim, K; Rumizen, Mj; Nahar, S; Podar, K; Chauhan, D; Hideshima, T; Carrasco, Dr; Munshi, Nc; Afar, D; Anderson, Kc
Impact on local control and survival of electron beam intraoperative irradiation (IORT) for resectable pancreatic adenocarcinoma (PA)
2000-01-01 Reni, M; Panucci, Mg; Ferreri, Ajm; Balzano, G; Passoni, P; Cattaneo, Gm; Zerbi, A; Ceresoli, Gl; Di Carlo, V; Villa, E.
Synthetic Lethal Approaches to Exploit Replicative Stress in Aggressive Myeloma
2014-01-01 Cottini, F; Hideshima, T; Suzuki, R; Richardson, Pg; Anderson, Kc; Tonon, G
Retrospective analysis of post-surgical therapy in low grade (LG) and anaplastic (AN) oligodendrogliomas (O) and oligoastrocytomas (OA)
1999-01-01 Reni, M; Franzin, A; Mossini, R; Ferreri, Ajm; Truci, G; Ferrari, C; Canal, N; Villa, E.
Spectral karyotyping (SKY) in combination with locus-specific FISH, a technique to simultaneously define genes and chromosomes involved in chromosomal translocations
1999-01-01 Tonon, G; Roschke, A; Kuehl, Wm; Kirsch, Ir
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Lentiviral vector-based insertional mutagenesis identifies new clinically relevant cancer genes involved in the pathogenesis of hepatocellular carcinoma | 1-gen-2011 | Ranzani, M; Cesana, D; Bartholomae, C; Sanvito, F; Pala, M; Benedicenti, F; Gallina, P; Sergi, L; Merella, S; Bulfone, A; Doglioni, C; von Kalle, C; Kim, Yj; Schmidt, M; Tonon, G; Naldini, L; Montini, E | |
| Association between DNA repair polymorphisms and survival in cancer cancer patients treated with combination chemotherapy | 1-gen-2010 | Pacetti, P; Giovanetti, E; Reni, M; Mambrini, A; Ghidini, M; Gleon, L; Funel, N; Cereda, S; Peters, G; Cantore, M. | |
| Loss of the Histone Demethylase UTX Contributes to Multiple Myeloma and Sensitizes Cells to EZH2 Inhibitors | 1-gen-2014 | Ezponda, T; Popovic, R; Zheng, Yp; Nabet, B; Will, C; Small, Ec; Occhionorelli, M; Tonon, G; Keats, Jj; Kelleher, Nl; Licht, Jd | |
| Adjuvant PEFG (cisplatin, epirubicin, 5-fluorouracil, gemcitabine) or gemcitabine in pancreatic cancer: a randomized phase II trial | 1-gen-2009 | Reni, M; Cereda, S; Aprile, G; Tronconi, Mc; Milandri, C; Passoni, P; Rognone, A; Balzano, G; Di Carlo, V; Villa, E | |
| Up-regulation of c-Jun contributes to induction of apoptosis by Adaphostin in human multiple myeloma cells | 1-gen-2005 | Podar, K; Tonon, G; Raab, Ms; Sattler, M; Abtahi, D; Tai, Yt; Legouill, S; Ishitsuka, K; Yasui, H; Depinho, Ra; Hideshima, T; Chauhan, D; Anderson, Kc | |
| TUMOR DOWNSTAGING AND SPHINCTER PRESERVATION WITH PREOPERATIVE CHEMORADIOTHERAPY FOR RECTAL CANCER | 1-gen-2004 | Ronzoni, M; Vitali, G; Reni, M; Di Palo, S; Staudacher, C; Villa, E | |
| HIGH-THROUGHPUT SEQUENCING FOR THE IDENTIFICATION OF DIS3 MUTATIONS IN MULTIPLE MYELOMA | 1-gen-2015 | Barbieri, M; Lionetti, M; Todoerti, K; Agnelli, L; Fabris, S; Cifola, I; Pinatel, E; Tonon, G; Segalla, S; Baldini, L; Neri, A | |
| Adjuvant chemotherapy in ductal adenocarcinoma of pancreas: a comparison among three regimens | 1-gen-2002 | Reni, M; Panucci, Mg; Balzano, G; Ferreri, Aj; Passoni, P; Zerbi, A; Cordio, S; Ceresoli, Gl; Dell'Oro, S; Staudacher, C; Di Carlo, V; Villa, E. | |
| The AP-1 Transcription Factor JunB Promotes Multiple Myeloma (MM) Cell Proliferation, Survival and Drug Resistance in the Bone Marrow Microenvironment | 1-gen-2014 | Fan, Fj; Vallet, S; Sattler, M; Tonon, G; Bashari, Mh; Bakiri, L; Goldschmidt, H; Wagner, Ef; Jaeger, D; Podar, K | |
| Hypofractioniated (HF) RT of locally advanced pancreatic cancer: A planning design | 1-gen-2006 | Cattaneo, G; Passoni, P; Esposito, D; Bettinardi, B; Reni, M; Broggi, S; Tamborra, P; Di Muzio, N; Fazio, F; Calandrino, R | |
| Maintenance sunitinib (MS) or observation (O) in metastatic pancreatic adenocarcinoma (MPA): Clinical and translational results of a phase II randomized trial | 1-gen-2012 | Reni, M; Cereda, S; Milella, M; Novarino, A; Passardi, A; Mambrini, A; Di Lucca, G; Ferrari, L; Belli, C; Danova, M; Bergamo, F; Franceschi, E; Rovati, B; Fugazza, C; Ceraulo, D; Villa, E | |
| Targeting PKC informs in MM by enzastaurin (LY317615.HCL) | 1-gen-2007 | Raab, Ms; Podar, K; Zhang, J; Tonon, G; Mcmillin, D; Breitkreutz, I; Tai, Yt; Lin, B; Munshi, N; Hideshima, T; Chauhan, D; Anderson, Kc | |
| A RANDOMIZED PHASE II TRIAL OF TWO DIFFERENT FOUR DRUG COMBINATIONS IN ADVANCED PANCREATIC ADENOCARCINOMA: CISPLATIN, CAPECITABINE, GEMCITABINE PLUS EITHER EPIRUBICIN OR DOCETAXEL | 1-gen-2009 | Cereda, S; Reni, M; Rognone, A; Ghidini, M; Rezzonico, S; Passoni, P; Mazza, E; Belli, C; Zerbi, A; Villa, E | |
| The Role of the ABL1/YAP1/P73 Axis in Prevention of DNA Damage-Mediated Apoptosis in Multiple Myeloma | 1-gen-2012 | Cottini, F; Hideshima, T; Sattler, M; Caligaris-Cappio, F; Anderson, Kc; Tonon, G | |
| Recurrent glioblastoma multiforme: a multicenter phase II study with fractionated temozolomide (bid) plus cisplatin | 1-gen-2002 | Basso, U; Vastola, F; Reni, M; Et, Al. | |
| CS1 Promotes Multiple Myeloma Cell Adhesion, Clonogenic Growth, and Tumorigenicity Via C-Maf-Mediated Interactions with Bone Marrow Stromal Cells (BMSC) | 1-gen-2008 | Tai, Yt; Soydan, E; Fulciniti, M; Song, Wh; Li, Xf; Burger, P; Hong, Fx; Tonon, G; Kim, K; Rumizen, Mj; Nahar, S; Podar, K; Chauhan, D; Hideshima, T; Carrasco, Dr; Munshi, Nc; Afar, D; Anderson, Kc | |
| Impact on local control and survival of electron beam intraoperative irradiation (IORT) for resectable pancreatic adenocarcinoma (PA) | 1-gen-2000 | Reni, M; Panucci, Mg; Ferreri, Ajm; Balzano, G; Passoni, P; Cattaneo, Gm; Zerbi, A; Ceresoli, Gl; Di Carlo, V; Villa, E. | |
| Synthetic Lethal Approaches to Exploit Replicative Stress in Aggressive Myeloma | 1-gen-2014 | Cottini, F; Hideshima, T; Suzuki, R; Richardson, Pg; Anderson, Kc; Tonon, G | |
| Retrospective analysis of post-surgical therapy in low grade (LG) and anaplastic (AN) oligodendrogliomas (O) and oligoastrocytomas (OA) | 1-gen-1999 | Reni, M; Franzin, A; Mossini, R; Ferreri, Ajm; Truci, G; Ferrari, C; Canal, N; Villa, E. | |
| Spectral karyotyping (SKY) in combination with locus-specific FISH, a technique to simultaneously define genes and chromosomes involved in chromosomal translocations | 1-gen-1999 | Tonon, G; Roschke, A; Kuehl, Wm; Kirsch, Ir |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 4 Contributo in Atti di Convegno ...3021
Data di pubblicazione
- In corso di stampa1
- 2020 - 2026373
- 2010 - 2019988
- 2000 - 20091246
- 1990 - 1999399
- 1985 - 198914
Editore
- SAGE PUBLICATIONS LTD152
- LIPPINCOTT WILLIAMS & WILKINS85
- WILEY49
- ELSEVIER30
- Edizioni Minerva Medica22
- OXFORD UNIV PRESS18
- ELSEVIER SCIENCE INC15
- CELL PRESS13
- Società Italiana di Igiene, Medic...11
- BMJ PUBLISHING GROUP10
Rivista
- MULTIPLE SCLEROSIS157
- BLOOD77
- NEUROLOGY76
- INVESTIGATIVE OPHTHALMOLOGY & VIS...65
- EUROPEAN JOURNAL OF NEUROLOGY46
- ANNALS OF ONCOLOGY44
- ANNALS OF THE RHEUMATIC DISEASES27
- GASTROENTEROLOGY26
- HAEMATOLOGICA23
- MOLECULAR THERAPY21
Serie
- IFMBE PROCEEDINGS1
- INTERNATIONAL CONFERENCE ON PATTE...1
- PROCEEDINGS INTERNATIONAL SYMPOSI...1
- RADIOTHERAPY AND ONCOLOGY1
Keyword
- FA16
- ICG16
- MRI16
- OCT16
- RTA16
- SLO16
- Systemic Sclerosis14
- rehabilitation7
- ultrasound)7
- Keywords: imaging methods (CT6
Lingua
- eng1259
- ita451
- fre23
- und21
- ger1
- jpn1
- por1
Accesso al fulltext
- no fulltext2963
- reserved35
- open23